Perfect Medical Health Management Limited AI Stock Analysis
Want to see HK:1830 full AI Analyst Report?
Perfect Medical Health Management Limited (1830) AI Stock Analysis
Perfect Medical Health Management Limited
(HKEX:1830)
The score is supported primarily by solid profitability, strong cash generation, attractive valuation, and moderate leverage. Technical momentum is favorable but materially overbought, while revenue pressure and declining assets and equity limit further upside.
Perfect Medical Health Management Limited (1830) vs. iShares MSCI Hong Kong ETF (EWH)
- Market Cap
- HKD 1.93B
- Dividend Yield
- 9.32%
- Average Volume (3M)
- 498.49K
- Price to Earnings (P/E)
- 11.0
- Beta (1Y)
- 0.63
- Revenue Growth
- -14.68%
- EPS Growth
- -13.60%
- Country
- Hong Kong
- Employees
- 787
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Care Facilities
Perfect Medical Health Management Limited Business Overview & Revenue Model
Company Description
Operating as an investment holding firm, Perfect Medical Health Management Limited delivers a comprehensive suite of medical and aesthetic services across Hong Kong, mainland China, Macau, Singapore, and Australia. Its offerings encompass medical aes...
Perfect Medical Health Management Limited Financial Statement Overview
Summary
Strong profitability and cash generation support the score, while moderate leverage is manageable. Slowing revenue and declining assets and equity are the main weaknesses.
Income Statement
74PositiveBalance Sheet
71PositiveCash Flow
79Positive| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 962.35M | 962.35M | 1.13B | 1.39B | 1.39B | 1.35B |
| Gross Profit | 538.03M | 454.45M | 719.22M | 911.37M | 662.60M | 689.93M |
| EBITDA | 368.03M | 369.52M | 441.97M | 596.91M | 592.40M | 602.84M |
| Net Income | 178.72M | 178.72M | 206.90M | 315.80M | 315.64M | 305.25M |
Balance Sheet | ||||||
| Total Assets | 834.20M | 834.20M | 935.91M | 1.22B | 1.30B | 1.28B |
| Cash, Cash Equivalents and Short-Term Investments | 294.93M | 294.93M | 386.80M | 567.40M | 656.85M | 454.37M |
| Total Debt | 134.58M | 134.58M | 216.65M | 268.73M | 240.35M | 311.07M |
| Total Liabilities | 446.33M | 446.33M | 557.18M | 725.00M | 684.02M | 786.93M |
| Stockholders Equity | 387.86M | 387.86M | 379.95M | 497.51M | 612.27M | 494.27M |
Cash Flow | ||||||
| Free Cash Flow | 309.22M | 309.22M | 298.23M | 445.50M | 533.81M | 372.16M |
| Operating Cash Flow | 339.48M | 339.48M | 332.88M | 497.12M | 560.55M | 516.71M |
| Investing Cash Flow | -180.16M | -180.16M | -171.93M | 162.56M | -222.51M | 8.05M |
| Financing Cash Flow | -269.94M | -269.94M | -477.95M | -520.97M | -335.02M | -565.97M |
Perfect Medical Health Management Limited Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1830, the sentiment is Positive. The current price of 1.58 is above the 20-day moving average (MA) of 1.20, above the 50-day MA of 1.23, and above the 200-day MA of 1.19, indicating a bullish trend. The MACD of 0.06 indicates Negative momentum. The RSI at 86.38 is Negative, neither overbought nor oversold. The STOCH value of 94.32 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:1830.
Perfect Medical Health Management Limited Peers Comparison
Overall Rating
- HK:183077Outperform
HK:144856Neutral
HK:252152Neutral
HK:848350Neutral
HK:091948Neutral
HK:829643Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| HK:1830 | 77Outperform | HKD 1.96B | 10.96 | 43.78% | 9.32% | -14.68% | -13.60% |
| HK:1448 | 56Neutral | HKD 6.03B | 14.04 | 6.50% | 6.27% | ― | ― |
| HK:2521 | 52Neutral | HKD 1.76B | 48.42 | 6.47% | ― | 2.78% | -41.23% |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| HK:8483 | 50Neutral | HKD 248.00M | -24.93 | -77.06% | ― | -38.43% | -394.12% |
| HK:0919 | 48Neutral | HKD 67.84M | -37.50 | -0.93% | ― | -2.31% | 66.07% |
| HK:8296 | 43Neutral | HKD 14.93M | -0.67 | -17.95% | ― | -26.00% | -188.55% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| HK:1830 | Perfect Medical Health Management Limited | 1.58 | 0.35 | 28.25% | |
| HK:1448 | Fu Shou Yuan International Group | 2.64 | -0.27 | -9.31% | |
| HK:0919 | Modern Healthcare Technology Holdings Limited | 0.07 | 0.00 | 2.74% | |
| HK:8296 | Sino-Life Group Limited | 0.16 | -0.22 | -57.89% | |
| HK:8483 | Max Sight Group Holdings Limited | 0.35 | 0.21 | 150.00% | |
| HK:2521 | Shenghui Cleanness Group Holdings Limited | 0.90 | 0.42 | 87.50% |
Perfect Medical Health Management Limited Corporate Events
Perfect Medical Reports Preliminary Profit Surge on Efficiency Gains
Perfect Medical Health Management Limited is a listed healthcare management group operating across Hong Kong, Australia, Singapore and Macau, with overseas operations forming part of its market focus.A preliminary assessment indicates profit attribut...
Perfect Medical Sets Date to Review Interim Results and Dividend
Perfect Medical Health Management Limited said its board is scheduled to meet on Nov. 16, 2026, to approve the company and subsidiaries’ interim results for the six months ended Sept. 30, 2026, and authorize their publication. Directors will also con...
Perfect Medical Announces Board Resignation and Committee Reshuffle
Perfect Medical Health Management Limited has announced the resignation of independent non-executive director Mr. Chi Chi Hung, Kenneth, effective 30 September 2026. His departure also covers his roles as chairman of the remuneration committee and as...
Perfect Medical Updates Board and Committee Structure to Strengthen Governance
Perfect Medical Health Management Limited has outlined the composition of its board of directors effective 30 September 2026, led by Chairman and Chief Executive Officer Dr. Au-Yeung Kong and supported by three executive and three independent non-exe...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 11, 2026